The results of multivariate analysis using linear regression model adjusted for multiple parameters confirmed that increased activated CD69+ B cells were universally present in JAK2-mutated, CALR-mutated and triple-negative ET patients when compared to healthy adults, although the number of total B- cells was significantly lower in ET patients (Table 4). This evidence concerns the gene CD69 and essential thrombocythemia.